Cover Image
市場調查報告書

全球馬的健康管理市場預測

Global Equine Healthcare Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 323243
出版日期 內容資訊 英文 90 Pages
訂單完成後即時交付
價格
Back to Top
全球馬的健康管理市場預測 Global Equine Healthcare Market 2015-2019
出版日期: 2015年01月21日 內容資訊: 英文 90 Pages
簡介

包含對馬來說QOL(生活品質)的改善、壽命延長化、高品質的馬用食物的開發等獸醫學部門的馬的健康管理市場,預計從2014年到2019年以1.24%的年複合成長率發展。

本報告提供全球馬的健康管理市場相關調查、市場背景及概要、 市場現況與展望的相關調查、市場概要、各終端用戶(產業/個人)的市場規模的變化與預測、地區及主要國家趨勢、市場成長的各種影響因素分析、競爭環境,以及主要企業的簡介等彙整。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品種類市場

  • 全球馬的健康管理市場
    • 診斷產品
    • 治療產品
    • 補充品
  • 全球馬疫苗市場
    • 市場規模與預測

第8章 各地區市場

第9章 購買標準

第10章 市場成長因素

第11章 成長因素與其影響

第12章 市場課題

第13章 成長因素與課題的影響

第14章 市場趨勢

第15章 趨勢與其影響

第16章 業者情勢

  • 競爭模式
    • 主要消息
    • M&A

第17章 市場佔有率分析

  • Affymetrix
  • Bayer Health Care
    • 各終端用戶
  • Boehringer Ingelheim
  • Elanco
    • 各終端用戶
    • 各地區
  • Merck Animal Health
    • 各終端用戶區分
    • 各地區
  • Purina Animal
  • Zoetis
    • 各品種類型
    • 各產品類型
    • 各地區
    • 各國
    • 各終端用戶
  • 其他卓越供應商

第18章 主要供應商分析

  • Affymetrix
  • Bayer HealthCare
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Merck Animal Health
  • Purina
  • Zoetis
    • 主要資料
    • 產業概要
    • 各部門市場收益
    • 各地區市場收益
    • 產業策略
    • 最近的發展趨勢
    • SWOT分析

第19章 相關報告

圖表一覽

目錄
Product Code: IRTNTR5065

About Equine Healthcare

Equine health refers to veterinary services intended to treat horses to enhance their quality of life, increase their lifespan, and develop better quality animal food. Equine diagnostic products, equine therapeutic products, and equine supplement products are the three major product types discussed in this report. Equine diagnostic products help to detect bacteria, antibodies, and viruses; equine therapeutic products include vaccination that helps treat any disease condition; and equine supplement products help in maintaining specific requirement of supplements.

TechNavio's analysts forecast the Global Equine Healthcare market to decline at a CAGR of 1.24 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Equine Healthcare market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various equine healthcare products. In terms of product, the Global Equine Healthcare market can be divided into three segments: Equine Diagnostic Products, Equine Therapeutic Products, and Equine Genotype Analysis.

TechNavio's report, the Global Equine Healthcare Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Equine Healthcare market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Affymetrix
  • Bayer Health Care
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Merck Animal Health
  • Purina Animal
  • Zoetis

Other Prominent Vendors

  • Boerhringer Ingelheim Vetmedica
  • Ceva Holdings
  • Merial
  • Novartis Animal Health
  • Signostics
  • Vetoquinol

Market Driver

  • Increase in Demand
  • For a full, detailed list, view our report

Market Challenge

  • Decrease in Global Equine Population
  • For a full, detailed list, view our report

Market Trend

  • Increase in Awareness
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Products

  • 07.1. Global Equine Vaccines Market
    • 07.1.1. Market Size and Forecast

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions

17. Market Share Analysis 2014

  • 17.1. Affymetrix
  • 17.2. Bayer Health Care
    • 17.2.1. Segmentation by End-user
  • 17.3. Boehringer Ingelheim
  • 17.4. Elanco
    • 17.4.1. Segmentation by End-user
    • 17.4.2. Segmentation by Geography
  • 17.5. Merck Animal Health
    • 17.5.1. Segmentation by End-user
    • 17.5.2. Segmentation by Geography
  • 17.6. Purina Animal
  • 17.7. Zoetis
    • 17.7.1. Segmentation by Species Type
    • 17.7.2. Segmentation by Product Type
    • 17.7.3. Segmentation by Geography
    • 17.7.4. Segmentation by Country
    • 17.7.5. Segmentation by End-user
  • 17.8. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Affymetrix
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation
    • 18.1.4. Business Segmentation by Revenue 2013
    • 18.1.5. Business Segmentation by Revenue 2012 and 2013
    • 18.1.6. Sales by Geography
    • 18.1.7. Business Strategy
    • 18.1.8. Key Information
    • 18.1.9. SWOT Analysis
  • 18.2. Bayer HealthCare
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation by Revenue 2013
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Geographical Segmentation by Revenue 2013
    • 18.2.6. Business Strategy
    • 18.2.7. Recent Developments
    • 18.2.8. SWOT Analysis
  • 18.3. Boehringer Ingelheim
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2013
    • 18.3.4. Business Segmentation by Revenue 2012 and 2013
    • 18.3.5. Geographical Segmentation by Revenue 2013
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis
  • 18.4. Elanco Animal Health
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Strategy
    • 18.4.4. Recent Developments
    • 18.4.5. SWOT Analysis
  • 18.5. Merck Animal Health
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Business Strategy
    • 18.5.4. Recent Developments
    • 18.5.5. SWOT Analysis
  • 18.6. Purina
    • 18.6.1. Key Facts
    • 18.6.2. Business Overview
    • 18.6.3. Key Products
    • 18.6.4. Business Strategy
    • 18.6.5. Recent Developments
    • 18.6.6. SWOT Analysis
  • 18.7. Zoetis
    • 18.7.1. Key Facts
    • 18.7.2. Business Overview
    • 18.7.3. Business Segmentation by Revenue 2013
    • 18.7.4. Business Segmentation by Revenue 2012 and 2013
    • 18.7.5. Geographical Segmentation by Revenue 2013
    • 18.7.6. Business Strategy
    • 18.7.7. Recent Developments
    • 18.7.8. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Equine Healthcare Market 2014-2019 (US$ billion)
  • Exhibit 3: Global Equine Healthcare Market: Segmentation by Product
  • Exhibit 4: Global Equine Healthcare Market: Segmentation 2014
  • Exhibit 5: Global Equine Vaccines Market 2014-2019 (US$ billion)
  • Exhibit 6: Global Equine Healthcare Market by Geographical Segmentation 2014
  • Exhibit 7: Affymetrix Year on Year Sales Comparison 2010-2013 (US$ million)
  • Exhibit 8: Bayer's Revenue by Segment 2013
  • Exhibit 9: Bayer Animal Health: Segmentation by End-user
  • Exhibit 10: Eli Lilly: Revenue by Segment 2013
  • Exhibit 11: Elanco: Segmentation by End-user
  • Exhibit 12: Elanco: Revenue by Geography 2013
  • Exhibit 13: Merck: Revenue by Segment 2013
  • Exhibit 14: Merck Animal Health: Segmentation by End-user
  • Exhibit 15: Merck Animal Health: Segmentation by End-user
  • Exhibit 16: Merck Animal Health: Segmentation by Geography 2013
  • Exhibit 17: Land O Lakes Year on Year Sales Comparison 2010-2013 (US$ million)
  • Exhibit 18: Zoetis: Segmentation by Species Type
  • Exhibit 19: Zoetis: Revenue of Species Type Segmentation 2013
  • Exhibit 20: Zoetis: Segmentation by Product Type
  • Exhibit 21: Zoetis: Revenue of Product Type Segmentation 2013
  • Exhibit 22: Zoetis: Revenue of Geographical Segmentation 2013
  • Exhibit 23: Zoetis: Revenue Segmentation by Geography
  • Exhibit 24: Zoetis: Revenue of Country-wise Segmentation 2013
  • Exhibit 25: Zoetis: Segmentation by End-user
  • Exhibit 26: Zoetis: Revenue of End-user Segment 2013
  • Exhibit 27: Zoetis: Companion Animals Segmentation by Product Type
  • Exhibit 28: Zoetis: Companion Animals Segmentation by Species Type
  • Exhibit 29: Zoetis: Revenue of Companion Animals Segment by Species Type 2013
  • Exhibit 30: Zoetis: Revenue of Companion Animals Segment by Geography 2013
  • Exhibit 31: Affymetrix Inc.: Business Segmentation 2013
  • Exhibit 32: Affymetrix Inc.: Business Segmentation by Revenue 2013
  • Exhibit 33: Affymetrix Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 34: Affymetrix Inc.: Sales by Geography 2013
  • Exhibit 35: Bayer HealthCare: Business Segmentation by Revenue 2013
  • Exhibit 36: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 37: Bayer HealthCare: Geographical Segmentation by Revenue 2013
  • Exhibit 38: Boehringer Ingelheim: Business Segmentation by Revenue 2013
  • Exhibit 39: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 40: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
  • Exhibit 41: Purina: Key Products
  • Exhibit 42: Zoetis: Business Segmentation by Revenue 2013
  • Exhibit 43: Zoetis: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 44: Zoetis: Geographical Segmentation by Revenue 2013
Back to Top